Ultra-rapid lispro is more protective against exercise-associated hypoglycaemia over lispro in adults with type 1 diabetes on continuous subcutaneous insulin infusion

被引：0
|
作者：
Leohr, J. [1 ]
Abibol, A. [2 ]
LaBell, E. Smith [1 ]
Ghosh, A. [1 ]
Turner, L. V. [3 ]
Shakeri, D. [3 ]
Fukuda, T. [1 ]
Riddell, M. C. [2 ,3 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] LMC Healthcare, Centr Res, Toronto, ON, Canada
[3] York Univ, Muscle Hlth Res Ctr, Toronto, ON, Canada
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
12
引用
收藏
页码：S9 / S9
页数：1
相关论文
共 50 条
  • [41] Ultra-rapid lispro improved postprandial glucose control compared to insulin lispro in predominantly Chinese patients with type 1 diabetes: A prospective, randomized, double-blind phase 3 study
    Ma, Jianhua
    Yan, Xiang
    Feng, Qiong
    Liu, Wei
    Perez Manghi, Federico
    Garcia-Hernandez, Pedro
    Wang, Guixia
    Xu, Jianwei
    Yuan, Yuan
    Zhou, Zhiguang
    DIABETES OBESITY & METABOLISM, 2024, 26 (01): : 311 - 318
  • [42] Continuous Subcutaneous Insulin Infusion for Adults with Type 1 Diabetes Mellitus
    Shamliyan, Tatyana A.
    Lee, Clare J.
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (11): : 1255 - +
  • [43] BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study
    Heise, Tim
    Meiffren, Gregory
    Alluis, Bertrand
    Seroussi, Cyril
    Ranson, Aymeric
    Arrubla, Jorge
    Correia, Jose
    Gaudier, Martin
    Soula, Olivier
    Soula, Remi
    DeVries, J. Hans
    Klein, Oliver
    Bode, Bruce
    DIABETES OBESITY & METABOLISM, 2019, 21 (04): : 1066 - 1070
  • [44] Fully closed-loop with ultra-rapid insulin lispro improves glycaemic control compared to pump therapy with CGM in adults with type 1 diabetes: a randomised crossover study
    Boughton, C. K.
    Lakshman, R.
    Hartnell, S.
    Nwokolo, M.
    Ware, J.
    Allen, J. M.
    Wilinska, M. E.
    Evans, M. L.
    Hovorka, R.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S387 - S387
  • [45] Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes A randomized open parallel multicenter study
    Bolli, Geremia B.
    Kerr, David
    Thomas, Reena
    Torlone, Elisabetta
    Sola-Gazagnes, Agnes
    Vitacolonna, Ester
    Selam, Jean Louis
    Home, Philip D.
    DIABETES CARE, 2009, 32 (07) : 1170 - 1176
  • [46] THE EFFECT OF THE ULTRA-RAPID INSULIN ANALOG FIASP® IN PEDIATRIC TYPE 1 DIABETES PATIENTS UNDER CONTINUOS SUBCUTANEOUS INSULIN INFUSION (CSII)
    Costa, C.
    Caetano, J.
    Bastos, F.
    Linhares, M. I.
    Cardoso, R.
    Dinis, I.
    Santos, A. P.
    Mirante, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A91 - A91
  • [47] Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog® (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial
    Helle Linnebjerg
    Qianyi Zhang
    Elizabeth LaBell
    Mary Anne Dellva
    David E. Coutant
    Ulrike Hövelmann
    Leona Plum-Mörschel
    Theresa Herbrand
    Jennifer Leohr
    Clinical Pharmacokinetics, 2020, 59 : 1589 - 1599
  • [48] Uptake of Continuous Subcutaneous Insulin Infusion Therapy by Adults with Type 1 Diabetes
    Gajewska, Katarzyna Anna
    Sreenan, Seamus
    Biesma, Regien
    Bennett, Kathleen
    DIABETES, 2019, 68
  • [49] Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog(R)(Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial
    Linnebjerg, Helle
    Zhang, Qianyi
    LaBell, Elizabeth
    Dellva, Mary Anne
    Coutant, David E.
    Hoevelmann, Ulrike
    Plum-Moerschel, Leona
    Herbrand, Theresa
    Leohr, Jennifer
    CLINICAL PHARMACOKINETICS, 2020, 59 (12) : 1589 - 1599
  • [50] Continuous subcutaneous insulin infusion (CSII) of insulin aspart vs. insulin lispro in paediatric subjects (ages 4 to 18 years) with type 1 diabetes (T1D)
    Ternand, C.
    Weinzimer, S. A.
    Laffel, L. M. B.
    Howard, C.
    Chang, C.-T.
    Becker, D. J.
    DIABETOLOGIA, 2007, 50 : S83 - S84
12345